MAIA Biotechnology Inc (MAIA)
1.99
+0.02
(+1.02%)
USD |
NYAM |
Dec 24, 16:00
MAIA Biotechnology Free Cash Flow: -15.79M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
Emergent BioSolutions Inc | 138.10M |
Regeneron Pharmaceuticals Inc | 3.319B |
Aspira Womens Health Inc | -14.59M |
Catalent Inc | 99.00M |
NovaBay Pharmaceuticals Inc | -4.812M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -3.525M |
Cash from Financing (Quarterly) | 0.6268M |
Free Cash Flow Per Share (Quarterly) | -0.1475 |
Free Cash Flow Yield | -40.08% |